{"id":"W3083807864","doi":"10.1016/j.jchf.2020.06.015","title":"Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause","year":2020,"lang":"en","type":"article","venue":"JACC Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; Sanofi Pasteur; Baxter Healthcare Corporation; National Institutes of Health; DalCor Pharmaceuticals; Novo Nordisk; GlaxoSmithKline; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Bayer Fund; Actavis; Boston Scientific Corporation; British Heart Foundation; Cytokinetics; AbbVie; Bayer; Gilead Sciences; AstraZeneca; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Novartis; Merck; Akebia Therapeutics; Bristol-Myers Squibb; Pfizer; Boehringer Ingelheim; Amgen; Abbott Laboratories; Kidney Research UK; Medtronic","keywords":"Medicine; Implantable cardioverter-defibrillator; Hazard ratio; Internal medicine; Valsartan; Sacubitril, Valsartan; Heart failure; Cardiology; Ejection fraction; Sudden cardiac death; Sacubitril; Cardiomyopathy; Confidence interval; Blood pressure","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001186075,0.0004810943,0.000882862,0.001018109,0.0003662197,0.0009728191,0.0005401266,0.0009016254,0.003424858],"category_scores_gemma":[0.00158677,0.0004094439,0.002593417,0.0009446605,0.0003612858,0.0006933378,0.0006110994,0.001222777,0.0003827645],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003812665,"about_ca_system_score_gemma":0.000539429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0046922,"about_ca_topic_score_gemma":0.007684262,"domain_scores_codex":[0.9993855,0.0002037461,0.00005712182,0.0001041353,0.00008306715,0.0001665564],"domain_scores_gemma":[0.9986191,0.0004390015,0.0004088699,0.0001133262,0.0000804546,0.0003391843],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02245317,0.0005543555,0.9586384,0.0002842684,0.005392173,0.0003035369,0.0001658042,0.0004767693,0.001429936,0.0003631202,0.001041041,0.008897307],"study_design_scores_gemma":[0.0006029209,0.001627297,0.993755,0.00003403266,0.001592993,0.0002641789,0.0002253932,0.0006987536,0.0001705906,0.0001920715,0.0008044606,0.00003228835],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993444,0.003276636,0.00008464836,0.0001164999,0.00006122875,0.00001719436,0.0009383732,0.000009558261,0.002051993],"genre_scores_gemma":[0.9966407,0.0009813458,0.00007639489,0.0001155396,0.0001072618,0.00002209785,0.000992923,0.000005462683,0.00105836],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0046922,"threshold_uncertainty_score":0.01145726,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04087361945055903,"score_gpt":0.2864771530589053,"score_spread":0.2456035336083463,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}